Lung Neoplasms: all 7,334 studies
Page 50 of 74. Open to participants first (1,555), then studies with results posted, then the rest; newest registration first within each.
- RT Plus EGFR-TKI for Wild-type NSCLCStatus unknownNCT02738983Phase 2
- SBRT Compared With IMRT Concurrently With Chemotherapy in Treating Patients With LS-SCLCStatus unknownNCT02738723Phase 2
- Detection Cell Free DNA in Lung Cancer PatientsStatus unknownNCT02738593
- Paclitaxel Detection in NSCLC Treated With TC RegimenTerminatedNCT02737709Phase 2
- Retrospective Epidemiological Study of Lung Cancer With Low-dose Multislice Computed TomographyCompletedNCT02736643
- Novel Lung Imaging in Adults Undergoing Radiation Therapy to Assess for Radiation PneumonitisCompletedNCT02735746
- A Clinical Research of NK Cell Infusion Combined With Chemotherapy in the Treatment of Non-small Cell Lung CancerStatus unknownNCT02734524Phase 2
- Pembrolizumab With Nab-Paclitaxel in Non-Small Cell Lung CancerCompletedNCT02733250Phase 1/2
- The Efficacy and Safety of Apatinib Combined With Etoposide in Heavily Pretreated Advanced Non-small Cell Lung CancerStatus unknownNCT02733107Phase 2
- Clinician-Patient Communication in Lung Cancer CareActive, not recruitingNCT02732834
- Safety, Tolerability and Pharmacokinetics of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With ChemotherapyCompletedNCT02728492Phase 1
- National Lung Cancer Registry in Men and Women Based on Diagnosis in AlgeriaCompletedNCT02725892
- STUDY 15 - Comparing Gemcitabine/Carboplatin and Hydroxychloroquine Versus Carboplatin/Etoposide Therapy Alone in Small Cell Lung Cancer (SCLC)TerminatedNCT02722369Phase 2
- Hypofractionated Radiation Therapy Combined With Concurrent Chemotherapy for Patients With Non-small Cell Lung CancerCompletedNCT02720614Phase 2
- EBUS TBNA After PET/CT in Diagnosing Patients With Stage I-IIA Non-small Cell Lung Cancer Evaluated for Stereotactic Body Radiation TherapyCompletedNCT02719847
- Blood-based Identification and Monitoring of Patients With ALK-translocated Lung CancerCompletedNCT02718651
- Comparison Between Wedge Resection and Segmentectomy for Ground Glass Opacity- Dominant Stage IA NSCLCStatus unknownNCT02718365Not applicable
- Combination of Cetuximab With Afatinib for Patient With EGFR Mutated Lung CancerCompletedNCT02716311Phase 2
- Wholebody MRI In Lung Cancer StagiNgCompletedNCT02716051Not applicable
- Circulating Tumor DNA in Patients at High Risk for Lung CancerTerminatedNCT02715102
- A Study of Ginsenoside H Dripping Pills for Advanced Non-Small Cell Lung Cancer (NSCLC)Status unknownNCT02714608Phase 2
- EGFR-TKI Concurrent With/Without WBRT in Brain Metastasis From NSCLCStatus unknownNCT02714010Phase 3
- Use of EBUS TBNA for Cell Culture as an Aid to Diagnose Lung Cancer and LymphomaCompletedNCT02710565Not applicable
- An Observational Research Of Crizotinib's Hepatic Toxicity In Non-small Cell Lung Cancer PatientsStatus unknownNCT02708667
- A Clinical Test for the Treatment of Multifocal Lung Cancers Using Genome SequencingTerminatedNCT02705404
- Rociletinib Genomic Landscape in Non-small Cell Lung Cancer (NSCLC)WithdrawnNCT02705339Phase 2
- Role of Geriatric Intervention in Treatment of Older Patients With Cancer (PREPARE)CompletedNCT02704832Not applicable
- Treatment Patients With Pulmonary Metastasis of Liver Cancer With Apatinib Combination With TACE: a Clinical StudyStatus unknownNCT02702323Phase 2/3
- 18F-Fluoroazomycin Arabinoside (18F-FAZA) in Lung CancerActive, not recruitingNCT02701699Not applicable
- Low-frequency Rotating Magnetic System Combined With Systemic Anti-tumor Therapy for Advanced Lung CancerStatus unknownNCT02701231Not applicable
- A Study to Evaluate the Clinical Efficacy of JNJ-42756493 (Erdafitinib), A Pan-Fibroblast Growth Factor Receptor (FGFR) Tyrosine Kinase Inhibitor, In Asian Participants With Advanced Non-Small-Cell Lung Cancer, Urothelial Cancer, Esophageal Cancer Or CholangiocarcinomaCompletedNCT02699606Phase 2
- Non-linear Multimodal Microendoscopy for Lung Cancer PathologyWithdrawnNCT02699229
- Plan for Systematic Identification of Lung Cancers of Occupational Origin: Implementation StudyStatus unknownNCT02696863
- Circulating Tumor DNA Detection in Surveillance of Surgical Lung Cancer PatientsStatus unknownNCT02696525
- A Study of Prevalence of EGFR Mutations in Participants With NSCLCCompletedNCT02695849
- Lung SBRT Motion Management (GCC 1619)TerminatedNCT02695680
- Study of Safety, Efficacy and Pharmacokinetics of CT-707 in Patients With ALK-positive Non-small Cell Lung CancerStatus unknownNCT02695550Phase 1
- CT Perfusion Imaging in Predicting Treatment Response in Patients With Non-small Cell Lung Cancer or Lung Metastases Treated With Stereotactic Ablative Radiation TherapyCompletedNCT02693080Phase 1
- Phase II, Single-arm Study of AZD1775 Monotherapy in Relapsed Small Cell Lung Cancer Patients With MYC Family Amplification or CDKN2A Mutation Combined With TP53 MutationTerminatedNCT02688907Phase 2
- Safety and Efficacy of DC-CIK in Patients With Advanced Non-Small-Cell Lung Cancer With Bone MetastasesStatus unknownNCT02688686Phase 1/2
- DC Vaccine Combined With CIK Cells in Patients With SCLCStatus unknownNCT02688673Phase 1/2
- Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LD-SCLCCompletedNCT02688036Phase 3
- Prevalence of Sleep Disordered Breathing in a Lung Cancer Screening CohortCompletedNCT02687997Not applicable
- The PACO Project: A Clinical Study of a PAtient COach Program in Vulnerable Lung Cancer PatientsStatus unknownNCT02686775Not applicable
- Vitamin Supplementation in NSCLC Patients on Pemetrexed Based ChemotherapyCompletedNCT02679443Not applicable
- Visualising c-MET and Activated Neutrophils in Lung CancerTerminatedNCT02676050Early Phase 1
- Investigation of Cannabis for Pain and Inflammation in Lung CancerWithdrawnNCT02675842Phase 1
- Trial of Ado-Trastuzumab Emtansine for Patients With HER2 Amplified or Mutant CancersCompletedNCT02675829Phase 2
- Comparable Study of Different Thoracic Radiotherapy Regimens for Extensive Stage Small Cell Lung CancerStatus unknownNCT02675088Not applicable
- Preoperative High Intensity Interval Training: The PHIIT TrialCompletedNCT02674815Not applicable
- Phase 2 Trial of Durvalumab With or Without Bavituximab in Patients With Previously Treated Metastatic Non-small-cell Lung CancerWithdrawnNCT02673814Phase 2
- MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s)TerminatedNCT02673021Not applicable
- Study of Efficacy and Safety of Dabrafenib and Trametinib Combination Therapy in Japanese Patients With BRAF V600E Stage IV NSCLCWithdrawnNCT02672358Phase 2
- Genomic Profiling in Previously Untreated Metastatic Non-small Cell Lung CancerTerminatedNCT02671045
- Cellular Immunotherapy Synergize Chemotherapy in Patients With Stage IV NSCLCStatus unknownNCT02669719Phase 2
- Novel Detection System for Lung Cancer Curative Effect MonitoringStatus unknownNCT02666755
- Percutaneous Cryoablation Peripheral Lung CancerStatus unknownNCT02665390Not applicable
- National Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung CancerCompletedNCT02664935Phase 2
- Use of [18]F-FDG on PET/CT as an Alternative Non-invasive Method for Staging of Lung CancerCompletedNCT02664792Not applicable
- Transcutaneous Electrical Acupoint Stimulation for Non-small Cell Lung Cancer PatientsStatus unknownNCT02663492Not applicable
- A Safety and Feasibility Study of AGS-003-LNG for the Treatment of Stage 3 Non Small Cell Lung CancerWithdrawnNCT02662634Phase 2
- A Trial of CDX-1401 in Combination With Poly-ICLC and Pembrolizumab, in Previously Treated Advanced Solid Tumor PatientsWithdrawnNCT02661100Phase 1/2
- Neutropenic Sepsis in Patients With Non-Small Cell Lung Cancer Treated With Single-Agent Docetaxel and Associated Resource Use in the UKCompletedNCT02658747
- Safety and Efficacy of Vitamin C Infusion in Combination With Local mEHT to Treat Non Small Cell Lung CancerCompletedNCT02655913Phase 1/2
- Electromagnetic Navigational Bronchoscopy Vs. Transthoracic Needle Biopsy for the Sampling of Peripheral Lung NodulesWithdrawnNCT02651506Phase 2
- D-CIK Combined With Chemotherapy for Non-Small Cell Lung Cancer(NSCLC)Status unknownNCT02651441Phase 1/2
- Efficacy of a Smart Management Strategy for Health (SMASH) Program for Overcoming Cancer Crisis and Growing PositivelyCompletedNCT02650661Not applicable
- LCL161 Plus Topotecan for Patients With Relapsed/Refractory Small Cell Lung Cancer and Select Gynecologic MalignanciesTerminatedNCT02649673Phase 1
- Continuous Activity Monitoring During Fractionated Radiotherapy in Patients With Head and Neck, Lung, or Gastrointestinal CancerCompletedNCT02649569
- The Value Of Circulating Tumor Cells In Patient With NSCLC In Postoperative Recurrence MonitoringStatus unknownNCT02647164
- Aprepitant vs. Desloratadine in EGFR-TKIs Related Pruritus TreatmentCompletedNCT02646020Phase 2
- Comparison of Circulating Tumor DNA and Tumor Tissue DNA by Targeted Sequencing in Non-Small Cell Lung CancerCompletedNCT02645318
- EGFR Mutation Detection From Advanced NSCLC Patient Tissue and Plasma in EGFR-TKI TreatmentStatus unknownNCT02644889
- Tocotrienol as a Nutritional Supplement in Patients With Advanced Lung CancerTerminatedNCT02644252Phase 3
- Nedaplatin/Docetaxel Versus Cisplatin/Docetaxel in Treatment of Advanced/Relapsed Squamous Cell Lung CancerStatus unknownNCT02643407Phase 3
- Study of Oral Mifepristone as Salvage Therapy in Patients With Advanced or Metastatic Non-Small Cell Lung CancerTerminatedNCT02642939Phase 2
- McMaster Catheterization for Thoracoscopic Surgery StudyWithdrawnNCT02640326Not applicable
- Vigil™ + Nivolumab in Advanced Non-Small Cell Lung CancerWithdrawnNCT02639234Phase 2
- Selective HDAC6 Inhibitor ACY 241 in Combination With Nivolumab in Patients With Unresectable Non Small Cell Lung CancerTerminatedNCT02635061Phase 1
- Study Comparing Bevacizumab + Erlotinib vs Erlotinib Alone as First Line Treatment of Patients With EGFR Mutated Advanced Non Squamous Non Small Cell Lung CancerStatus unknownNCT02633189Phase 3
- Circulating Tumor Cells (CTC) in Lung CancerActive, not recruitingNCT02630615
- Afatinib in Lung Cancer With EGFR Mutation From Circulating Tumor DNACompletedNCT02629523Phase 2
- Afatinib vs Erlotinib as 2nd TKI After Failure to 1st TKI and Chemotherapy for Metastatic NSCLCCompletedNCT02625168Phase 2
- The Watch the Spot TrialCompletedNCT02623712Not applicable
- EGFR Mutations on ctDNA in Patients With Advanced NSCLCCompletedNCT02623257
- Preventive Effects of Zoledronic Acid on Bone Metastasis in Patients With Stage IIIB and IV Lung CancerStatus unknownNCT02622607Phase 3
- Initial Oral Vinorelbine Dosing Schedules in Clinical Routine in Germany and AustriaCompletedNCT02619929
- A Retrospective Study About Treatment Strategy After First/Second Line EGFR-TKI FailureStatus unknownNCT02618590
- An Integrated Approach to Treating Recurrent Thoracic Carcinomas Resistant to Tyrosine Kinase InhibitorsCompletedNCT02616211
- Registry Study on Biological Disease Profile and Clinical Outcome in Patients With Newly Diagnosed or Existent Lung Cancer The LuCa Biology and Outcome (BiO)-ProjectStatus unknownNCT02613637
- Lung Cancer Indicator DetectionCompletedNCT02612532Not applicable
- LDCT Screening in Non-smokers in TaiwanActive, not recruitingNCT02611570
- A Prospective, Observational Trial on the Diagnostic and Prognostic of LMStatus unknownNCT02607605
- Fludeoxyglucose F-18 PET/CT in Predicting Response to Chemotherapy in Patients With Stage IIIA Non-small Cell Lung Cancer That Can Be Removed by SurgeryWithdrawnNCT02607423Phase 2
- Truthful Information on Chemotherapy and Its Impact on Chemotherapy at the End of LifeCompletedNCT02606149Not applicable
- Prevalence of COPD in Our Lung Cancer Population, Compared to ControlsStatus unknownNCT02603627
- Efficacy Study of Clinical Nutrition to Treat Lung Neoplasms And Breast CarcinomaCompletedNCT02603016Not applicable
- the"Fuzheng" Therapy of TCM to Improve the Survival Quality of Early-stage NSCLC by Intervening the CTCsCompletedNCT02603003Phase 1
- A Feasibility Study to Further the Development of Lung Cancer-based Precision MedicineActive, not recruitingNCT02597738Not applicable
- Program on Lung Cancer Screening and Tobacco CessationCompletedNCT02597491Not applicable